Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113477752 | 11347775 | 2 | F | 2005 | 20160622 | 20150803 | 20160706 | EXP | US-ELI_LILLY_AND_COMPANY-US201110001323 | ELI LILLY AND CO | 0.00 | M | Y | 0.00000 | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113477752 | 11347775 | 1 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 20 MG, QD | Y | Y | 0 | 20 | MG | TABLET | QD | ||||
| 113477752 | 11347775 | 2 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 10 MG, QD | Y | Y | 0 | 10 | MG | TABLET | QD | ||||
| 113477752 | 11347775 | 3 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 10 MG, QD | Y | Y | 0 | 10 | MG | TABLET | QD | ||||
| 113477752 | 11347775 | 4 | PS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 10 MG, QD | 20592 | 10 | MG | QD | |||||||
| 113477752 | 11347775 | 5 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | UNK UNK, UNKNOWN | Y | U | 0 | ||||||||
| 113477752 | 11347775 | 6 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Y | 0 | |||||||||||
| 113477752 | 11347775 | 7 | C | RISPERDAL | RISPERIDONE | 1 | Y | 0 | |||||||||||
| 113477752 | 11347775 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113477752 | 11347775 | 1 | Schizophrenia |
| 113477752 | 11347775 | 4 | Schizophrenia |
| 113477752 | 11347775 | 5 | Blood cholesterol increased |
| 113477752 | 11347775 | 6 | Schizophrenia |
| 113477752 | 11347775 | 7 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113477752 | 11347775 | HO |
| 113477752 | 11347775 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113477752 | 11347775 | Abnormal behaviour | |
| 113477752 | 11347775 | Aggression | |
| 113477752 | 11347775 | Back injury | |
| 113477752 | 11347775 | Blood cholesterol increased | |
| 113477752 | 11347775 | Blood triglycerides increased | |
| 113477752 | 11347775 | Chest pain | |
| 113477752 | 11347775 | Constipation | |
| 113477752 | 11347775 | Diarrhoea | |
| 113477752 | 11347775 | Fatigue | |
| 113477752 | 11347775 | Glucose tolerance impaired | |
| 113477752 | 11347775 | Hyponatraemia | |
| 113477752 | 11347775 | Insomnia | |
| 113477752 | 11347775 | Limb injury | |
| 113477752 | 11347775 | Poor quality sleep | |
| 113477752 | 11347775 | Rhabdomyolysis | |
| 113477752 | 11347775 | Tooth disorder | |
| 113477752 | 11347775 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113477752 | 11347775 | 2 | 2000 | 2006 | 0 | |
| 113477752 | 11347775 | 3 | 2011 | 0 | ||
| 113477752 | 11347775 | 4 | 2011 | 0 |